Delaware bioscience companies welcomed leaders from several European science and healthcare groups to the Delaware Innovation Space at the DuPont Experimental Station Friday.
They’re hoping to start conversations and connections allowing them to work together to bring newer technologies to the market.
At the Dupont Experimental Station, many local health professionals talked about their own research and where they’re interested in going forward with it.
Kris Vaddi is the CEO and founder of Prelude Therapeutics, a nine-month-old start-up trying to develop new medicines to treat cancer. He said Delaware is especially a great place for small start-ups in this industry.
“Many academic institutions where there’s a lot of cutting-edge research being done are all within driving distance or a short train ride. It’s a very accessible place,” Vaddi said.
Eric Kmiec is the director of the gene editing institute at the Helen F. Graham Cancer Center at Christiana Care Health System.
“I think just the feedback you get from people from other parts of the world who are sometimes less informed, sometimes more informed about the challenges of biopharmaceutical work — it’s a good knowledge base an important connections that can happen out of this kind of thing.”
Kmiec said meetings like this also help Delaware researchers and pharmaceutical companies understand what each other is doing.
Representatives from Global Delaware say they hope to create collaboration between European companies, Delaware companies and the greater Philadelphia region.
Global Delaware hosted the event as part of its mission to boost international investment in the First State.